Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bongmi is a digital health and medical technology company specializing in women's and children's health, primarily through its flagship brand, Femometer. Founded in 2014 and headquartered in Hangzhou, China, the company develops smart hardware integrated with AI-driven mobile applications to provide personalized health insights. Its core product line includes smart basal thermometers and hormone-tracking ovulation tests that assist users in monitoring fertility, predicting ovulation, and managing reproductive health. Beyond fertility, Bongmi has expanded its portfolio to include pediatric health solutions, such as smart growth trackers, and wellness applications focused on intermittent fasting and facial exercises. The company leverages data science and machine learning to empower women with accurate, actionable information for family planning and overall wellness. Bongmi's products are distributed globally, reaching users in hundreds of countries through major e-commerce platforms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bongmi.